Loading...
Drug therapy in anticoagulation: which drug for which patient?
Four non-vitamin K oral anticoagulants (NOACs) are now licensed and available in the UK, offering unprecedented choices in anticoagulant therapy for clinicians and patients. NOACs have many clear benefits over warfarin, the most striking being the reduction in intracranial haemorrhage. However, a nu...
Na minha lista:
| Udgivet i: | Clin Med (Lond) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Royal College of Physicians
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6297571/ https://ncbi.nlm.nih.gov/pubmed/28572224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.17-3-233 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|